NCT01938248 Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation Status COMPLETED Phase PHASE4
NCT01938144 Evaluation of the Efficacy and Safety of Two Ibuprofen Combination Products for the Treatment of the Common Cold and Flu in Latin America Status WITHDRAWN Phase PHASE3
NCT01937715 A Study Of PF-05212384 Plus FOLFIRI Versus Bevacizumab Plus FOLFIRI In Metastatic Colorectal Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT01936376 A Prospective Observational Study to Evaluate Acute Kidney Injury Biomarkers In Patients Receiving First Cycle of Cisplatin Chemotherapy for Head and Neck Cancers Status UNKNOWN Phase N/A
NCT01934738 A Study to Evaluate Safety, Toleration and Time Course of Plasma Concentration of Multiple Oral Doses of PF-06273340 in Healthy Subjects of Two AgeGroups, Aged 18-55 Years (Group 1) and Aged 56-75 Years (Group 2) Status COMPLETED Phase PHASE1
NCT01934452 Prospective Observational Analysis Of CR With Sunitinib Treatment In mRCC Patients Status COMPLETED Phase N/A
NCT01934140 Study to Evaluate the Long-term Antibody Persistence of GlaxoSmithKline (GSK) Biologicals' MenACWY-TT Vaccine (GSK134612) Versus Mencevax ACWY in Healthy Adolescents and Adults and Booster Response to MenACWY-TT Vaccine Administered at 10 Years Post-primary Vaccination Status COMPLETED Phase PHASE3
NCT01933672 Study Of Two Dosing Regimens Of PF-04937319 Compared To An Approved Agent (Sitagliptin) In Patients With Type 2 Diabetes Status COMPLETED Phase PHASE1
NCT01932372 Tofacitinib (Xeljanz) Special Investigation for Rheumatoid Arthritis Status COMPLETED Phase N/A
NCT01927341 Phase Ib/II Study of Efficacy and Safety of MEK162 and Panitumumab, in Adult mCRC Patients With Mutant or Wild-type RAS Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT01925456 Validation of Instruments for Pragmatic Clinical Trials for Overactive Bladder Status COMPLETED Phase PHASE1
NCT01925274 A Study Of PF-05212384 Plus Irinotecan Vs Cetuximab Plus Irinotecan In Patients With KRAS And NRAS Wild Type Metastatic Colorectal Cancer Status TERMINATED Phase PHASE2
NCT01924650 A Pharmacokinetic Study of Three Different Particle Sizes of PH-797804 Status WITHDRAWN Phase PHASE1
NCT01923389 Multiple Dose Study Of PF-05231023 In Obese Adult Subjects Status TERMINATED Phase PHASE1
NCT01920399 A Phase I Study to Assess the Safety, Tolerability and PK of Ceftazidime-Avibactam in Healthy Chinese Subjects Status COMPLETED Phase PHASE1
NCT01920061 A Study Of PF-05212384 In Combination With Other Anti-Tumor Agents and in Combination With Cisplatin in Patients With Triple Negative Breast Cancer in an Expansion Arm (TNBC) Status COMPLETED Phase PHASE1
NCT01919996 PASS Study To Evaluate The Potential Of Zithromax To Cause Ocular Problems In Pediatric Patients Status TERMINATED Phase PHASE2